1,200
Total Claims
$245K
Drug Cost
197
Beneficiaries
$1,244
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-12%
Cost per patient vs peers
$1,244 vs $1,411 avg
+59%
Brand preference vs peers
16.9% vs 10.6% avg
Brand vs Generic
83% generic
Brand: 203 claims · $224K
Generic: 997 claims · $21K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 118 | $155K |
| Rivaroxaban | 12 | $16K |
| Evolocumab | 11 | $7,632 |
| Icosapent Ethyl | 12 | $4,550 |
| Metoprolol Succinate | 89 | $2,264 |
| Rosuvastatin Calcium | 101 | $1,961 |
| Ranolazine | 11 | $1,720 |
| Atorvastatin Calcium | 87 | $1,401 |
| Losartan Potassium | 89 | $1,234 |
| Clopidogrel Bisulfate | 55 | $1,068 |
| Ezetimibe | 22 | $951 |
| Potassium Chloride | 39 | $892 |
| Carvedilol | 87 | $869 |
| Diltiazem Hcl | 23 | $861 |
| Isosorbide Mononitrate | 24 | $630 |
Prescribing Profile
24
Unique Drugs
$171K
Patient Profile
75
Avg Age
39%
Female
1.70
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About